|Articles|May 1, 2004
Phakic IOLs offer good outcomes to high myopes and hyperopes
The U.S. FDA study of the Implantable Collamer Lens (ICL, STAAR Surgical)used to treat high myopia (mean preoperative refraction, -10 D) and availablein four lengths (11.5 to 13 mm) shows good visual results in 526 eyes. Thesedata were presented at the American Society of Cataract and Refractive Surgery(ASCRS) annual meeting.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5
2
4DMT releases positive interim 1.5- to 3.5-year data from phase 1/2 PRISM trial
3
AAO 2025: A study of retinal vasculitis events with intravitreal agents
4
PolyActiva and RareSight partner to develop treatments for rare pediatric retinal diseases
5














































.png)


